Nfj Investment Group »

Supernus Pharmaceuticals shares owned by Nfj Investment Group

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Nfj Investment Group from 13F filings

Historical chart of Nfj Investment Group investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Nfj Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Nfj Investment Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 53k 51.69

More positions owned by Nfj Investment Group

Hf Sinclair Corp (DINO)
Marvell Technology (MRVL)
Charles Schwab Corporation (SCHW)
Prologis (PLD)
Alphabet Cap Stk Cl A (GOOGL)
Ge Vernova (GEV)
Commercial Metals Company (CMC)
Glacier Ban (GBCI)
Eli Lilly & Co. (LLY)
Nextera Energy (NEE)
Equinix (EQIX)
Royal Gold (RGLD)
Marathon Petroleum Corp (MPC)
Universal Hlth Svcs CL B (UHS)
Nutrien (NTR)

View all positions for Nfj Investment Group

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Millennium Management
Vanguard Portfolio Management
Vanguard Capital Management
Dimensional Fund Advisors
State Street Corporation
Nomura Asset Management International
Armistice Capital
Renaissance Technologies
Geode Capital Management
Citadel Advisors
Loomis, Sayles and
Stephens Investment Management Group
Point72 Asset Management

View all funds holding Supernus Pharmaceuticals